Macquarie Group’s Alnylam Pharmaceuticals ALNY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $296M | Buy |
|
|||||
|
2025
Q2 | $196M | Buy |
|
|||||
|
2025
Q1 | $19.6M | Buy |
|
|||||
|
2024
Q4 | $14.3M | Sell |
|
|||||
|
2024
Q3 | $20M | Buy |
|
|||||
|
2024
Q2 | $14.4M | Buy |
|
|||||
|
2024
Q1 | $8.36M | Buy |
|
|||||
|
2023
Q4 | $9M | Buy |
|
|||||
|
2023
Q3 | $8.13M | Buy |
|
|||||
|
2023
Q2 | $8.55M | Sell |
|
|||||
|
2023
Q1 | $9.16M | Buy |
|
|||||
|
2022
Q4 | $10.7M | Buy |
|
|||||
|
2022
Q3 | $8.86M | Buy |
|
|||||
|
2022
Q2 | $6.26M | Sell |
|
|||||
|
2022
Q1 | $7.06K | Buy |
|
|||||
|
2021
Q4 | $7.31M | Sell |
|
|||||
|
2021
Q3 | $10.1M | Hold |
|
|||||
|
2021
Q2 | $9.09M | Buy |
|
|||||
|
2021
Q1 | $7.55M | Buy |
|
|||||
|
2020
Q4 | $5.63M | Sell |
|
|||||
|
2020
Q3 | $6.43M | Sell |
|
|||||
|
2020
Q2 | $8.11M | Sell |
|
|||||
|
2020
Q1 | $6.13M | Sell |
|
|||||
|
2019
Q4 | $6.82M | Buy |
|
|||||
|
2019
Q3 | $4.75M | Sell |
|
|||||
|
2019
Q2 | $4.52M | Buy |
|
|||||
|
2019
Q1 | $5.43M | Buy |
|
|||||
|
2018
Q4 | $4.22M | Buy |
|
|||||
|
2018
Q3 | $5.03M | Buy |
|
|||||
|
2018
Q2 | $5.58M | Buy |
|
|||||
|
2018
Q1 | $5.11M | Buy |
|
|||||
|
2017
Q4 | $5.2M | Buy |
|
|||||
|
2017
Q3 | $1.53M | Sell |
|
|||||
|
2017
Q2 | $1.25M | Sell |
|
|||||
|
2017
Q1 | $885K | Sell |
|
|||||
|
2016
Q4 | $665K | Buy |
|
|||||
|
2016
Q3 | $1.09M | Sell |
|
|||||
|
2016
Q2 | $2.24M | Buy |
|
|||||
|
2016
Q1 | $56K | Hold |
|
|||||
|
2015
Q4 | $85K | Hold |
|
|||||
|
2015
Q3 | $72K | Sell |
|
|||||
|
2015
Q2 | $1.83M | Sell |
|
|||||
|
2015
Q1 | $2.08M | Sell |
|
|||||
|
2014
Q4 | $2.53M | Sell |
|
|||||
|
2014
Q3 | $2.19M | Sell |
|
|||||
|
2014
Q2 | $1.9M | Buy |
|
|||||
|
2014
Q1 | $1.83M | Sell |
|
|||||
|
2013
Q4 | $2.76M | Buy |
|
|||||
|
2013
Q3 | $1.67M | Buy |
|
|||||
|
2013
Q2 | $558K | Buy |
|